Bixin Xi
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Cancer-related molecular mechanisms research
- Dermatology top 5%
- Skin Protection and Aging
Papers in
-
- Cancer Genomics and Diagnostics 3
- Carcinogens and Genotoxicity Assessment 3
-
- Advanced Glycation End Products research 3
- Co-authors
- Timothy W. SynoldGerd P. PfeiferAhmad BesaratiniaQinglei GaoDongyi WanDan LiuDing MaCheng Chang
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Clinical Cancer Research (1 paper)Frontiers in Pediatrics (1 paper)Molecular Cancer Therapeutics (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Bixin Xi
23 papers receiving 839 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 196
- Dermatology 99
- Clinical Biochemistry 62
- Oncology 216
- Molecular Biology 488
Countries citing papers authored by Bixin Xi
This map shows the geographic impact of Bixin Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bixin Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bixin Xi more than expected).
Fields of papers citing papers by Bixin Xi
This network shows the impact of papers produced by Bixin Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bixin Xi. The network helps show where Bixin Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Bixin Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 19 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2018 | 90 | |
| 8 | 2017 | 85 | |
| 9 | 2016 | 19 | |
| 10 | 2015 | 26 | |
| 11 | 2014 | 75 | |
| 12 | 2014 | 52 | |
| 13 | 2012 | 24 | |
| 14 | 2012 | 25 | |
| 15 | 2011 | 67 | |
| 16 | 2007 | 12 | |
| 17 | 2005 | 18 | |
| 18 | 2005 | 16 | |
| 19 | 2005 | 124 | |
| 20 | 1996 | 3 |
About Bixin Xi
Bixin Xi is a scholar working on Cancer Research, Clinical Biochemistry, Virology, Neurology and Dermatology, having authored 26 papers that have together received 848 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Advanced Glycation End Products research (3 papers), Erythrocyte Function and Pathophysiology (2 papers), Neonatal Health and Biochemistry (2 papers), Cancer therapeutics and mechanisms (2 papers), Skin Protection and Aging (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Cancer Research (196 citations), Dermatology (99 citations), Clinical Biochemistry (62 citations), Oncology (216 citations) and Molecular Biology (488 citations). Bixin Xi has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Timothy W. Synold, Gerd P. Pfeifer, Ahmad Besaratinia, Qinglei Gao, Dongyi Wan, Dan Liu, Ding Ma, Cheng Chang, Arthur D. Riggs and Xiaoxue Zhang. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Frontiers in Pediatrics, Molecular Cancer Therapeutics and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.